OOIR: Observatory of International Research

Papers

(The H4-Index of Current Opinion in Immunology is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
The future of vaccination in Latin America: learning from the COVID-19 pandemic	269
Revisiting the role of MRGPRX2 on hypersensitivity reactions to neuromuscular blocking drugs	193
Gene: environment interactions in immune and inflammatory responses to severe acute respiratory syndrome coronavirus 2 infection	150
An easy pill to swallow: oral recombinant vaccines for the 21st century	84
Better living through chemistry: CRISPR/Cas engineered T cells for cancer immunotherapy	84
Inflammasome activation by SARS-CoV-2 and its participation in COVID-19 exacerbation	75
Oncogenic viruses, cancer biology, and innate immunity	72
TAP-ing into the cross-presentation secrets of dendritic cells	67
Mycobacterial diseases in patients with inborn errors of immunity	65
COVID-19 vaccines	63
A critical review of measures of childhood vaccine confidence	62
Principles and practical applications of structure-based vaccine design	60
AP-1 transcription factors in cytotoxic lymphocyte development and antitumor immunity	58
Ebola virus disease: current vaccine solutions	58
Increasing hepatitis B vaccination coverage of healthcare workers — global lessons for South Africa	57
Beyond the gastric epithelium — the paradox of Helicobacter pylori-induced immune responses	57
Necroptosis in immunity, tissue homeostasis, and cancer	57
Some thoughts about what non-mammalian jawed vertebrates are telling us about antigen processing and peptide loading of MHC molecules	56
Host genetics of innate immune system in infection	51
Innate antiviral immunity and immunometabolism in hepatocytes	50
Commander-in-chief: monocytes rally the troops for defense against aspergillosis	46
Safety switches for adoptive cell therapy	46
Immunological lessons from genome-wide association studies of infections	45
Nutritional modulation of antitumor immunity	44
Regulation of MHC class II and CD86 expression by March-I in immunity and disease	44

Metabolism and macrophages in the tumor microenvironment	43
Bioinspired vaccines to enhance MHC class-I antigen cross-presentation	42
Immunological scars after cure of hepatitis C virus infection: Long‐HepC?	40
Human MALT1 deficiency and predisposition to infections	39
Conformational sensing of major histocompatibility complex (MHC) class I molecules by immune receptors and intracellular assembly factors	38
Mapping and modelling human B cell maturation in the germinal centre	38
T follicular helper cells and their impact on humoral responses during pathogen and vaccine challenge	38
Signals governing monocyte differentiation during inflammation	37
Antibody glycosylation directs innate and adaptive immune collaboration	36
Monogenic autoimmunity and infectious diseases: the double-edged sword of immune dysregulation	36
Patterns of bacterial viability governing noncanonical inflammasome activation	36